- Home
- TVRD vs FTHM Comparison
TVRD vs FTHM Comparison
Compare TVRD & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TVRD | FTHM |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.3M | 42.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | TVRD | FTHM |
|---|---|---|
| Price | $3.64 | $1.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $51.67 | $2.50 |
| AVG Volume (30 Days) | 51.6K | ★ 111.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $335,184,000.00 |
| Revenue This Year | N/A | $30.07 |
| Revenue Next Year | N/A | $14.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.50 | $0.65 |
| 52 Week High | $43.65 | $3.37 |
Technical Indicators
Market Signals| Indicator | TVRD | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 43.13 |
| Support Level | $3.51 | $0.95 |
| Resistance Level | $3.89 | $1.08 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 23.40 | 34.78 |
Price Performance
Historical ComparisonAbout TVRD Tvardi Therapeutics Inc.
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.